Safety Study of ABT-888 Plus Topotecan Hydrochloride to Treat Patients With Solid Tumors and Lymphomas

NCT00553189 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

NIH

Sponsor class

Conditions

Solid Tumors
Lymphomas

Interventions

DRUG: ABT-888
DRUG: Topotecan

Sponsor

National Cancer Institute (NCI)